| TRADING CENTER |
| Options Update: Pfizer, Bristol-Meyers and Merck volatility low - Bloggingstocks.com | |
| For guys with a short sexual fuse, a new spray may help delay the grand finale - DailyFinance | |
| Don Dion's Weekly ETF Blog Wrap - at TheStreet.com | |
| Bristol, Pfizer to seek apixaban approval - Reuters | |
| Bristol-Myers, Pfizer To Seek Europe OK For Anticlotting Drug - Dow Jones | |
| FDA staff urge review of psychiatric drugs in kids - Reuters | |
| Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixab... - Business Wire | |
| UPDATE:FDA Staff Recommends Look At Child Weight Gain With Antipsychotics - Dow Jones | |
| After Rising 500%, What Did You Expect? - MotleyFool.com | |
| FDA Staff Recommends Antipsychotic Drug Review On Kid Weight Gain - Dow Jones | |
| FDA staff urge more antipsychotic review in kids - Reuters | |
| Bayer Advances on Alzheimer's Plan - Analyst Blog - Zacks.com | |
| Best Buys Now - MotleyFool.com | |
| Health-Care Reform Is Very Taxing - MotleyFool.com | |
| Two Ways to Play a Rise in Pharma ($) - at TheStreet.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 64.36 | 0.20 / 0.31% | 14.05 |
| NVS | Novartis AG | 55.55 | -0.23 / -0.41% | 15.60 |
| RHHBY | Roche Hldg Ltd | 41.42 | -0.43 / -1.03% | n/a |
| 2008 Revenue: | $48.3 B | Headquarters: New York, NY |
| Employees: | 81,800 | CEO: Jeffrey B. Kindler |
| Net Income: | $8.1 B | Industry: Pharmaceuticals |
| Market Cap: | $149.2 B | Website: www.pfizer.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| PFE | 18.49 | -0.15 / -0.80% | 18.64 | 18.95 | 18.44 | Profile Chart News |